A prescription for heart failure success: Change the name
June 5, 2017
PARIS – This condition’s very name dooms it to failure. Dr. Lynne Warner Stevenson has some ideas to fix that.
Spironolactone’s HFpEF benefit happens mostly in women
May 26, 2017
PARIS – What a new TOPCAT analysis reveals about sex differences in HFpEF
New heart failure guidelines prioritize prevention
May 18, 2017
The latest update to U.S. guidelines for heart failure management, released at the end of April , puts unprecedented emphasis on heart failure prevention and also shines a brighter light on patients at risk for developing heart failure – people with hypertension, diabetes, or coronary arte...
Oral iron of no benefit in heart failure with iron deficiency
May 16, 2017
High-dose oral iron therapy doesn’t improve exercise capacity in the estimated 50% of patients with symptomatic heart failure who also have iron deficiency, according to a report published online May 16 in JAMA.Iron deficiency in patients with HF, regardless of their hemoglobin status, is ...
PPIs triple heart failure hospitalization risk in atrial fib patients
May 10, 2017
PARIS – Atrial fib patients taking proton pump inhibitors, largely unnecessarily, have a far greater risk of hospitalization for an acute heart failure episode.
Noncardiovascular comorbidities spike in acute heart failure
May 1, 2017
PARIS – The biggest jump occurred in the prevalence of chronic obstructive pulmonary disease, which rose from 27% in 2005 to 35% in 2014.
What drives readmissions within 90 days after MI hospitalization
April 26, 2017
WASHINGTON – Cardiologists and hospitals gear up for switch to Medicare bundled payments for acute MI.
CRT-D beneficial in mild HF with ejection fraction above 30%
April 26, 2017
WASHINGTON – Risk of death was cut in half in new MADIT-CRT long-term substudy.
It’s been a good year for heart failure research … mostly
April 13, 2017
WASHINGTON – The highs ... and the lows.
Uptake of new heart failure drugs slow despite guidelines
April 5, 2017
Ivabradine and sacubitril/valsartan reduce mortality and hospitalizations.